Biblio

Export 1356 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2015
R. Migliaccio, Agosta, F., Possin, K. L., Canu, E., Filippi, M., Rabinovici, G. D., Rosen, H. J., Miller, B. L., and Gorno-Tempini, M. Luisa, “Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, 2015.
L. S. Pimentel, Allard, S., Carmo, S. Do, Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B., and A Cuello, C., “The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 2, pp. 373-83, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
F. Licastro, Raschi, E., Carbone, I., and Porcellini, E., “Variants in Antiviral Genes are Risk Factors for Cognitive Decline and Dementia.”, J Alzheimers Dis, 2015.
2016
Y. H. Fu, Hsiao, J. - H. T., Paxinos, G., Halliday, G. M., and Kim, W. Scott, “ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.”, J Alzheimers Dis, vol. 54, no. 2, pp. 569-84, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
A. Pliássova, Canas, P. M., Xavier, A. Carolina, da Silva, B. S., Cunha, R. A., and Agostinho, P., “Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1209-14, 2016.
S. Matura, Prvulovic, D., Hartmann, D., Scheibe, M., Sepanski, B., Butz, M., Oertel-Knöchel, V., Knöchel, C., Karakaya, T., Fußer, F., Hattingen, E., and Pantel, J., “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
S. Matura, Prvulovic, D., Hartmann, D., Scheibe, M., Sepanski, B., Butz, M., Oertel-Knöchel, V., Knöchel, C., Karakaya, T., Fußer, F., Hattingen, E., and Pantel, J., “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
A. Midorikawa, Leyton, C. E., Foxe, D., Landin-Romero, R., Hodges, J. R., and Piguet, O., “All Is Not Lost: Positive Behaviors in Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia with Disease Severity.”, J Alzheimers Dis, vol. 54, no. 2, pp. 549-58, 2016.
M. Perkins, Wolf, A. B., Chavira, B., Shonebarger, D., Meckel, J. P., Leung, L., Ballina, L., Ly, S., Saini, A., T Jones, B., Vallejo, J., Jentarra, G., and Valla, J., “Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.”, J Alzheimers Dis, vol. 53, no. 1, pp. 95-106, 2016.
F. Piazza and Winblad, B., “Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?”, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
M. Jeong Wang, Yi, S. H., Han, J. - Y., Park, S. Young, Jang, J. - W., Chun, I. Kook, Van Giau, V., Bagyinszky, E., Lim, K. Taek, Kang, S. Min, An, S. Soo A., Park, Y. Ho, Youn, Y. Chul, and Kim, S. Y., “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
M. Jeong Wang, Yi, S. H., Han, J. - Y., Park, S. Young, Jang, J. - W., Chun, I. Kook, Van Giau, V., Bagyinszky, E., Lim, K. Taek, Kang, S. Min, An, S. Soo A., Park, Y. Ho, Youn, Y. Chul, and Kim, S. Y., “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
M. Mandecka, Budziszewska, M., Barczak, A., Pepłońska, B., Chodakowska-Żebrowska, M., Filipek-Gliszczyńska, A., Nesteruk, M., Styczyńska, M., Barcikowska, M., and Gabryelewicz, T., “Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 157-68, 2016.
M. Siotto, Simonelli, I., Pasqualetti, P., Mariani, S., Caprara, D., Bucossi, S., Ventriglia, M., Molinario, R., Antenucci, M., Rongioletti, M., Rossini, P. Maria, and Squitti, R., “Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
E. Pretorius, Bester, J., and Kell, D. B., “A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1237-56, 2016.

Pages